Gilead unit’s experimental therapy shrink brain tumours by 62%
HQ Team June 2, 2025: An investigational therapy from Kite Pharma Inc., a Gilead Sciences company, has reduced tumours in 62% of the
HQ Team June 2, 2025: An investigational therapy from Kite Pharma Inc., a Gilead Sciences company, has reduced tumours in 62% of the
HQ Team June 1, 2025: An investigational oral breast cancer drug being developed by Pfizer and Arvinas Inc. has been shown to delay
HQ Team May 31, 2025: Autism and Parkinson’s disease share underlying biological mechanisms, and people with an autism diagnosis are four times more
HQ Team May 30, 2025: Stanford University, along with other researchers, has developed a set of gene delivery systems that can reach different
HQ Team May 29, 2025: Swiss-American Alcon Inc.’s acoltremon ophthalmic solution, Tryptyr, has received a green signal from the US Food and Drug
HQ Team May 29, 2025: The US Department of Health and Human Services has terminated a contract awarded to Moderna Inc. for the
HQ Team May 29, 2025: More than one million children are at risk of contracting cholera in war-torn Sudan, where 185 deaths have
HQ Team May 28, 2025: GSK Plc. and Spero Therapeutics have stopped their combined trial of an investigational oral treatment for urinary tract
By Aparna S. May 28, 2025: World Schizophrenia Day was observed recently to encourage society and mental health professionals to re-evaluate how we